Related Experiment Videos
A study of the interaction between lornoxicam and warfarin in healthy volunteers
M Ravic1, A Johnston, P Turner
1Department of Clinical Pharmacology, St. Bartholomew's Hospital, London, UK.
Human & Experimental Toxicology
|November 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Modelling long-term outcomes for patients with systemic lupus erythematosus.
Seminars in arthritis and rheumatism·2024
A review of analytical parameters in 'rapid' liquid chromatographic methods for bioanalysis: Can we do better?
Journal of chromatography. A·2024
Multi-perspective region-based CNNs for vertebrae labeling in intraoperative long-length images.
Computer methods and programs in biomedicine·2022
Current management of adults receiving oral anti-cancer medications: A scoping review.
European journal of oncology nursing : the official journal of European Oncology Nursing Society·2021
Establishment of a rat model of bronchopulmonary dysplasia complicated with pulmonary hypertension and its potential applications.
Human & experimental toxicology·2026
Pulmonary iron oxide (Fe3O4) nanoparticle-biomolecule interactions modified during aging and metabolic syndrome disease progression.
Human & experimental toxicology·2026
Stevioside inhibits colorectal cancer progression by regulating macrophage polarization.
Human & experimental toxicology·2026
Predictive factors of severe outcome in glufosinate ammonium poisoning: A retrospective study in Vietnam.
Human & experimental toxicology·2025
Usnic Acid induces dual-pathway apoptosis in SKOV-3 ovarian cancer cells via PARP1 inhibition and MAPK pathway activation.
Human & experimental toxicology·2025
Synergistic lipase inhibition by Garcinia parvifolia metabolites: a 1H NMR-based metabolomic deciphering of ligand interactions.
Metabolomics : Official journal of the Metabolomic Society·2026
Design, synthesis, and evaluation of fluorescent probes targeting DNA polymerase theta (Polθ) for inhibitor screening and cellular imaging.
European journal of medicinal chemistry·2026
Proteolysis Targeting Chimera (PROTAC) Linkerology Enhances the CDK-Degradation Selectivity Profile of a Multi-CDK Inhibitor: Discovery of Potent, Anti-Leukemic CDK9 Degraders.
ACS pharmacology & translational science·2026